Hormone-Refractory Prostate Cancer Unknown Status Phase 1 / 2 Trials for Picoplatin (DB04874)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00448734A Study of Picoplatin and Docetaxel in Subjects With Prostate CancerTreatment